alpha-Synuclein and intracellular trafficking: impact on the spreading of Parkinson's disease pathology

被引:51
|
作者
Eisbach, Sibylle E. [1 ]
Outeiro, Tiago F. [1 ]
机构
[1] Univ Med Ctr Gottingen, Ctr Nanoscale Microscopy & Mol Physiol Brain, Dept Neurodegenerat & Restorat Res, D-37073 Gottingen, Germany
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2013年 / 91卷 / 06期
关键词
alpha-Synuclein; Trafficking; Spreading; Prion; Transmission; Parkinson's disease; TO-NEURON TRANSMISSION; N-TERMINAL ACETYLATION; SUBSTANTIA-NIGRA; RAB GTPASES; SYNAPTIC DYSFUNCTION; AXONAL-TRANSPORT; IRON CONTENT; CELL-DEATH; IN-VITRO; MEMBRANE;
D O I
10.1007/s00109-013-1038-9
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Parkinson's disease is characterized by intracellular proteinaceous depositions known as Lewy bodies. These largely consist of the protein alpha-synuclein, whose physiological function remains unclear, but mutations and overexpression of the protein have been shown to cause early onset cases of Parkinson's disease. Deregulation of alpha-synuclein biology causes neurodegeneration and impaired neuronal trafficking, hinting at a possible contribution to the pathological mechanism. Recent studies produced some evidence hinting at the involvement of several regulators of the transport machinery such as Rab GTPases and SNARE proteins, but also shown that alpha-synuclein can be propagated between cells. Here, we discuss the molecular interplay of alpha-synuclein with the intracellular transport machinery, its consequences, and the implications for disease mechanisms.
引用
收藏
页码:693 / 703
页数:11
相关论文
共 50 条
  • [31] Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease
    Dolgacheva L.P.
    Fedotova E.I.
    Abramov A.Y.
    Berezhnov A.V.
    Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology, 2018, 12 (1) : 10 - 19
  • [32] Alpha-Synuclein in Peripheral Tissues in Parkinson's Disease
    Ma, Ling-Yan
    Liu, Gen-Liang
    Wang, Dong-Xu
    Zhang, Mei-Mei
    Kou, Wen-Yi
    Feng, Tao
    ACS CHEMICAL NEUROSCIENCE, 2019, 10 (02): : 812 - 823
  • [33] Parkinson's Disease, Cortical Dysfunction, and Alpha-Synuclein
    Caviness, John N.
    Lue, Lih-Fen
    Beach, Thomas G.
    Hentz, Joseph G.
    Adler, Charles H.
    Sue, Lucia
    Sadeghi, Ramin
    Driver-Dunckley, Erika
    Evidente, Virgilio G.
    Sabbagh, Marwan N.
    Shill, Holly A.
    Walker, Douglas G.
    MOVEMENT DISORDERS, 2011, 26 (08) : 1436 - 1442
  • [34] Alpha-Synuclein and the Endolysosomal System in Parkinson's Disease: Guilty by Association
    Teixeira, Maxime
    Sheta, Razan
    Idi, Walid
    Oueslati, Abid
    BIOMOLECULES, 2021, 11 (09)
  • [35] Alpha-Synuclein Effects on Mitochondrial Quality Control in Parkinson's Disease
    Shen, Lydia
    Dettmer, Ulf
    BIOMOLECULES, 2024, 14 (12)
  • [36] Clues to How Alpha-Synuclein Damages Neurons in Parkinson's Disease
    Sulzer, David
    MOVEMENT DISORDERS, 2010, 25 (03) : S27 - S31
  • [37] Alpha-synuclein, Proteotoxicity and Parkinson's Disease: Search for Neuroprotective Therapy
    Ganguly, Upasana
    Chakrabarti, Sankha Shubhra
    Kaur, Upinder
    Mukherjee, Anwesha
    Chakrabarti, Sasanka
    CURRENT NEUROPHARMACOLOGY, 2018, 16 (07) : 1086 - 1097
  • [38] Diagnostic and therapeutic agents that target alpha-synuclein in Parkinson's disease
    Nwabufo, Chukwunonso K.
    Aigbogun, Omozojie P.
    JOURNAL OF NEUROLOGY, 2022, 269 (11) : 5762 - 5786
  • [39] Functions of Intracellular Alpha-Synuclein in Microglia: Implications for Parkinson's Disease Risk
    Booms, Alix
    Coetzee, Gerhard A.
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2021, 15
  • [40] The interaction between alpha-synuclein and mitochondrial dysfunction in Parkinson's disease
    Li, Hong-Yan
    Liu, De-Shui
    Zhang, Ying-Bo
    Rong, Hua
    Zhang, Xiao-Jie
    BIOPHYSICAL CHEMISTRY, 2023, 303